Immunogenicity of COVID-19 Vaccination in Patients With Axial Spondyloarthritis: A Monocentric Prospective Belgian Cohort Study

Q2 Medicine

The Journal of rheumatology. Supplement Pub Date : 2022-03-01 DOI:10.3899/jrheum.211313

T. Vandergraesen, L. Mekkaoui, H. Dahma, M. Soyfoo, L. Tant

引用次数: 1

Abstract

Vaccination is cardinal in restraining the pandemic of COVID-19 caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The increased risk of severe COVID-19 infection in patients with inflammatory rheumatic diseases (IRD) makes vaccination particularly relevant in this population (1).

查看原文本刊更多论文

COVID-19疫苗接种对轴型脊柱炎患者的免疫原性:一项单中心前瞻性比利时队列研究

预防接种是遏制由严重急性呼吸综合征冠状病毒2型(SARS-CoV-2)引起的COVID-19大流行的关键。炎症性风湿病(IRD)患者严重感染COVID-19的风险增加，使得这一人群尤其需要接种疫苗(1)。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

The Journal of rheumatology. Supplement Medicine-Medicine (all)

自引率

0.00%

发文量

期刊介绍： The Journal of Rheumatology is a monthly international serial edited by Duncan A. Gordon, The Journal features research articles on clinical subjects from scientists working in rheumatology and related fields, as well as proceedings of meetings as supplements to regular issues. Highlights of our 36 years serving Rheumatology include: groundbreaking and provocative editorials such as "Inverting the Pyramid," renowned Pediatric Rheumatology, proceedings of OMERACT and the Canadian Rheumatology Association, Cochrane Musculoskeletal Reviews, and supplements on emerging therapies.